4//SEC Filing
Balak Salesh 4
Accession 0001437749-22-013712
CIK 0001279695other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:08 AM ET
Size
11.4 KB
Accession
0001437749-22-013712
Insider Transaction Report
Form 4
Balak Salesh
Chief Financial Officier
Transactions
- Award
Common Stock
2022-05-27$0.77/sh+2,000$1,540→ 338,558 total
Holdings
- 721,000
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2023-04-20→ Common Stock (721,000 underlying) - 500,000
Performance Rights
Exp: 2025-03-24→ Common Stock (500,000 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (500,000 underlying) - 216,300
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2024-02-27→ Common Stock (216,300 underlying) - 250,000
Performance Rights
Exp: 2025-03-24→ Common Stock (250,000 underlying)
Footnotes (6)
- [F1]The price reported is stated in Australian dollars.
- [F2]The options are fully vested and became exercisable on 03/01/2021.
- [F3]206,000 of the stock options vested and became exercisable on 10/05/2016, 412,000 of the stock options vested and became exercisable on 12/31/2016 and 103,000 of the stock options vested and became exercisable on 02/23/2017.
- [F4]216,300 stock options vested and became exercisable on 12/31/2017.
- [F5]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
- [F6]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.
Documents
Issuer
UNIVERSAL BIOSENSORS INC
CIK 0001279695
Entity typeother
Related Parties
1- filerCIK 0001397500
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 6:08 AM ET
- Size
- 11.4 KB